<DOC>
	<DOCNO>NCT02382900</DOCNO>
	<brief_summary>In genital tract human papilloma virus ( HPV ) , especially type 6 11 cause genital wart , common viral sexually transmitted disease . The HPV 16 18 common oncogenic `` high-risk '' genotype cause approximately 70 % cervical cancer despite fact associate anogenital cancer , anus , vagina , vulva penis , cancer head neck . Current estimate 5.2 % cancer HPV associate . A large number study , include adult young female , demonstrate HPV vaccine highly immunogenic induce long lasting protection infection . Immunogenic vaccination result young men boys equally satisfactory quadrivalent HPV ( type 6 , 11 , 16 , 18 ) vaccine recommend men . The recommended vaccination scheme include three shot give second two month third six month initial shot . Recently , show use two shot scheme ( 0 6 month ) equally effective among girl . The purpose study determine immunogenicity non-inferior boy use two shot scheme compare young woman girl .</brief_summary>
	<brief_title>Two-dose Schedule Quadrivalent HPV Recombinant Vaccine 11-year-old Boys Mexico City</brief_title>
	<detailed_description />
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All child whose parent accept participation study . Fever , previous vaccination HPV , allergy vaccine component , thrombocytopenia , immunosuppression , diarrhea , vomit , dyscrasia , administration another antiviral vaccine previous 15 day .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>quadrivalent</keyword>
	<keyword>vaccine</keyword>
</DOC>